|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.62 HKD | +1.85% |
|
+12.23% | -35.46% |
| Apr. 25 | Ascentage Pharma to Present Four Studies at US Oncology Meet | MT |
| Apr. 09 | Ascentage Pharma Chairman Boosts Stake in Firm | MT |
Ascentage Pharma Group International reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 221.98 million compared to CNY 209.71 million a year ago. Net loss was CNY 925.64 million compared to CNY 882.92 million a year ago.
Basic loss per share from continuing operations was CNY 3.28 compared to CNY 3.35 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -35.46% | 641M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
ASCENTAGE PHARMA GROUP INTERNATIONAL 
